China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
15.18
-0.62 (-3.92%)
Aug 21, 2026, 3:04 PM CST

SHE:300294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
778.14573.741,3001,9611,5321,584
Short-Term Investments
-108.14----
Trading Asset Securities
1,9942,5492,1993,3623,1942,700
Cash & Short-Term Investments
2,7723,2313,4995,3244,7264,284
Cash Growth
-12.68%-7.67%-34.28%12.66%10.31%468.21%
Accounts Receivable
884.8919.69509.38275.92567.02588.08
Other Receivables
171.5249.1739.81264.4100.6267.9
Receivables
1,056968.86549.19540.32667.64655.98
Inventory
1,021996.2995.43556.94666.96676.84
Other Current Assets
162.8837.8914.756.4313.2529.4
Total Current Assets
5,0125,2345,0586,4286,0735,646
Property, Plant & Equipment
1,5631,6511,170676.62722.81771.33
Long-Term Investments
140.94356.41407.51100.39117.09144.96
Goodwill
617.53617.5372872.61663.84663.84
Other Intangible Assets
422.81495.56773.28269.31312.17169.47
Long-Term Deferred Tax Assets
125.6383.2373.5447.3444.9927.44
Long-Term Deferred Charges
148.99145.29145.988.1582.64161.62
Other Long-Term Assets
253.0343.8444.38146.8316.2437.2
Total Assets
8,2848,6268,4017,8298,0337,622

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
252.77507.51357.62126.35303.46277.53
Accrued Expenses
82.84421.14323.81274.14290.9261.19
Current Portion of Long-Term Debt
5.95--0.0322.180.08
Current Portion of Leases
-5.795.330.872.812.06
Current Income Taxes Payable
17.892.0812.448.5827.0941.45
Current Unearned Revenue
7.968.124.0812.2120.5812.97
Other Current Liabilities
331.5889.1647.0934.2638.3335.66
Total Current Liabilities
698.991,034750.38456.45705.34630.94
Long-Term Debt
58.347.07-22.15-22.15
Long-Term Leases
10.312.737.171.410.3711.3
Long-Term Unearned Revenue
16.6825.3919.5123.5227.0930.98
Long-Term Deferred Tax Liabilities
56.4968136.324.565.565.94
Total Liabilities
840.771,187913.38508.07748.35701.3

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
504.25504.25504.25504.25504.25511.63
Additional Paid-In Capital
4,0634,0634,0634,0634,0654,258
Retained Earnings
2,8882,8742,9182,7532,6162,259
Treasury Stock
------199.96
Comprehensive Income & Other
-13.71-3.522.36---
Total Common Equity
7,4427,4387,4877,3207,1866,829
Minority Interest
1.251.550.611.0799.1991.4
Shareholders' Equity
7,4437,4397,4887,3217,2856,920
Total Liabilities & Equity
8,2848,6268,4017,8298,0337,622

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
74.5565.5912.5124.4535.3635.58
Net Cash (Debt)
2,6983,1653,4865,2994,6904,248
Net Cash Growth
-14.78%-9.22%-34.21%12.99%10.41%903.09%
Net Cash Per Share
5.216.186.9410.499.339.74
Filing Date Shares Outstanding
520.09504.25504.25504.25504.25504.25
Total Common Shares Outstanding
520.09504.25504.25504.25504.25504.25
Working Capital
4,3134,2004,3085,9715,3685,015
Book Value Per Share
14.3114.7514.8514.5214.2513.54
Tangible Book Value
6,4026,3255,9866,9786,2105,996
Tangible Book Value Per Share
12.3112.5411.8713.8412.3111.89
Buildings
-655.73741.4527.95518.01536.62
Machinery
-715.37839.25625.83671.97665.73
Construction In Progress
-938.5732139.9469.3440.86